Collaborative Undergraduate HBCU Student Summer Prostate Cancer Training Program

Abstract : There is a critical need to increase the number of racially and ethnically diverse prostate cancer researchers. The purpose of this 3-year project is to develop a prostate cancer research training program at the Medical University of South Carolina (MUSC) with 12 students from the following three Historically Black Colleges and Universities (HBCUs) in South Carolina: Claflin University, South Carolina State University, and Voorhees College. These Student Fellows will participate in research internships in the laboratories/research units of senior prostate cancer research scientists at MUSC. The specific aims of the project are as follows: (1) to provide training in the basics of research design and methods to four Student Fellows each year through participation in the MUSC Summer Undergraduate Research Program (SURP), and (2) to immerse four Student Fellows each year in a prostate cancer research training curriculum. In 2009, four Student Fellows were identified, recruited to participate, and admitted to the DoD Collaborative Undergraduate HBCU Student Summer Prostate Cancer Training Program. The Student Fellows were matched with Research Mentors at MUSC, with whom they conducted research in the summer of 2009. Each Student Fellow prepared a scientific paper and gave a scientific presentation at the end of the Training Program. Each Student Fellow also completed an 8-week Kaplan Graduate Record Examination Test Preparation Course at a local Kaplan Center. A total of 73 students from the three HBCUs attended the Ernest E. Just Symposium at MUSC in February of 2010. In summary, in the summer of 2009, we provided state-of-the art comprehensive prostate cancer research education and training opportunities for four Student Fellows from HBCUs in South Carolina. Each Student Fellow prepared a scientific paper and gave a scientific presentation. Four Student Fellows have been selected to participate in the Training Program during the Summer of 2010.

[1]  P. Lu,et al.  Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells. , 2009, Molecular pharmaceutics.

[2]  H. Ichijo,et al.  The roles of ASK family proteins in stress responses and diseases , 2009, Cell Communication and Signaling.

[3]  M. Ford,et al.  Effects of Baseline Comorbidities on Cancer Screening Trial Adherence among Older African American Men , 2008, Cancer Epidemiology Biomarkers & Prevention.

[4]  H. Ichijo,et al.  Thioredoxin and TRAF Family Proteins Regulate Reactive Oxygen Species-Dependent Activation of ASK1 through Reciprocal Modulation of the N-Terminal Homophilic Interaction of ASK1 , 2007, Molecular and Cellular Biology.

[5]  P. Lu,et al.  The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells , 2007, Cancer Gene Therapy.

[6]  J. Whisstock,et al.  An overview of the serpin superfamily , 2006, Genome Biology.

[7]  N. Powe,et al.  Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials , 2006, Clinical trials.

[8]  J. Lévesque,et al.  Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization , 2005, The Journal of experimental medicine.

[9]  J. Ford,et al.  The science of recruiting minority populations to screening trials , 2004, Clinical trials.

[10]  S. Havstad,et al.  A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial , 2004, Clinical trials.

[11]  B. Tilley,et al.  Recruiting older African American men to a cancer screening trial (the AAMEN Project). , 2003, The Gerontologist.

[12]  S. Quinn,et al.  African Americans' views on research and the Tuskegee Syphilis Study. , 2001, Social science & medicine.

[13]  W. McCaskill-Stevens,et al.  Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Souhami,et al.  Attitudes of patients to randomised clinical trials of cancer therapy. , 1998, European journal of cancer.

[15]  G. Swanson,et al.  Recruiting minorities into clinical trials: toward a participant-friendly system. , 1995, Journal of the National Cancer Institute.

[16]  Stephen B. Thomas,et al.  The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. , 1991, American journal of public health.

[17]  D. Vigushin,et al.  Histone deacetylase inhibitors in cancer treatment. , 2002, Anti-cancer drugs.

[18]  W. McCaskill-Stevens,et al.  Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. , 2000, Annals of epidemiology.